| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/26/2002 | WO2002004481A3 Process to increase protein stability |
| 09/26/2002 | WO2002003922A3 Synthetic peptide for neurological disorders |
| 09/26/2002 | WO2002002626A3 Novel secreted proteins |
| 09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001095711A3 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 09/26/2002 | WO2001094600A3 Promoters for regulated gene expression |
| 09/26/2002 | WO2001090159B1 Compositions and methods for delivery of a molecule into a cell |
| 09/26/2002 | WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 09/26/2002 | WO2001070969A3 Regulation of human latrophilin-like g protein-coupled receptor |
| 09/26/2002 | WO2001061019A3 A dominant selectable marker for gene transformation and disruption in yeasts |
| 09/26/2002 | WO2001047953A3 Antibodies against plasma cells |
| 09/26/2002 | WO2001032289A9 Methods for preparing blood or plasma component solutions with improved concentrations |
| 09/26/2002 | WO2001025401A9 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 09/26/2002 | WO2001025255A9 Novel zinc finger protein |
| 09/26/2002 | WO2001023615A9 Anti-aging nucleic acid and protein targets |
| 09/26/2002 | WO2001023421A9 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 09/26/2002 | WO2001020012A9 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 09/26/2002 | WO2001019861A9 Apo-2 receptor antibodies |
| 09/26/2002 | WO2001019845A9 Cacna1g polynucleotide, polypeptide and methods of use therefor |
| 09/26/2002 | WO2001019393A9 Delivering to eucaryotic cells bacterial proteins that are secreted via type iii secretion systems |
| 09/26/2002 | WO2001016295A9 Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons |
| 09/26/2002 | WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use |
| 09/26/2002 | US20020138880 Isolating a cation transport gene (magnesium transport gene) comprises selecting from suitable vectors expressing plant or animal cDNAs in yeast for clones that confer a high tolerance to aluminum |
| 09/26/2002 | US20020138872 Transgenic plants; enhanced defense mechanisms to combat plant diseases; disease resistant plants |
| 09/26/2002 | US20020138869 Plant cell death system |
| 09/26/2002 | US20020138868 Modulating endoreduplication in a plant or part thereof which comprises modifying expression or activity of the transciption factor E2Fa; use of Arabidopsis thaliana nucleotide sequences |
| 09/26/2002 | US20020138867 Geminivirus resistant transgenic plants |
| 09/26/2002 | US20020138863 Transgenic knockout mouse with homozygous disruption in its endogenous endothelial receptor (FcRn) gene; animal model for autoimmune disorders; FcRn selectively protects antibodies of immunoglobulin G isotype from catabolism |
| 09/26/2002 | US20020138860 Novel uses of mammalian CCR6 receptors and related reagents |
| 09/26/2002 | US20020138858 Cd39/ecto-adpase as a treatment for thrombotic and ischemic disorders |
| 09/26/2002 | US20020138207 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 09/26/2002 | US20020137918 Immnunoglobulin light chain binding protein for use in immunoaffinity chromatography |
| 09/26/2002 | US20020137916 Sphingosine 1-phosphate receptor gene, sppr |
| 09/26/2002 | US20020137915 Conformational and topological protein regulation |
| 09/26/2002 | US20020137914 Novel human dectin proteins and polynucleotides encoding the same |
| 09/26/2002 | US20020137912 Polynucleotide with the activity of carbon starvation protein A (cstA); fermentative preparation of L-amino acids, such as L-lysine |
| 09/26/2002 | US20020137911 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 09/26/2002 | US20020137910 MN gene and protein |
| 09/26/2002 | US20020137909 Designated as "PRO19598" polypeptides; diagnosis and treatment of tumors |
| 09/26/2002 | US20020137908 Novel guanosine triphosphate (GTP) binding protein-coupled receptor protein, BG3 |
| 09/26/2002 | US20020137906 Nematode Caenorhabditis elegans (C. elegans); lin-8, lin-56, and lin-61 genes and polypeptides involved in cell proliferation; use in diagnosing and treating abnormal cell proliferation |
| 09/26/2002 | US20020137905 A membrane protein induced by interferons; treating and preventing cancer and viral infection; mediate trans-bilayer movement of membrane phospholipids |
| 09/26/2002 | US20020137904 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 09/26/2002 | US20020137901 Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin |
| 09/26/2002 | US20020137900 Endothelial cell growth factor, methods of isolation and expression |
| 09/26/2002 | US20020137899 Crosslinked through one or more carbohydrate moieties in said glycoprotein; storage stability, chemical stability over wider range of conditions while retaining bioactivity in use |
| 09/26/2002 | US20020137898 Antibodies to natural killer stimulatory factor |
| 09/26/2002 | US20020137896 Of given amino acid sequence, found in edible mushroom Tricholoma matsutake |
| 09/26/2002 | US20020137895 Methods of protein purification and recovery |
| 09/26/2002 | US20020137894 Megakaryocyte stimulating factors |
| 09/26/2002 | US20020137893 Purification of NGF |
| 09/26/2002 | US20020137892 An isolated peptide transmitter-like receptor polypeptide with specific amino acid sequence or variant which has immunomodulatory, neuromodulatory and endocrinomodulatory activity |
| 09/26/2002 | US20020137891 Inserting a nucleic acid sequence encoding a heterologous polypeptide into a nucleic acid sequence encoding subunit of an oligomerisable protein scaffold, incorporating it into expression vector to express nucleic acid to produce monomer |
| 09/26/2002 | US20020137889 Stress resistant retroviruses |
| 09/26/2002 | US20020137887 Adenosine receptor |
| 09/26/2002 | US20020137886 Insertion of cleavage sites in non-critical regions of the toxins which are susceptible to protease activity in non-target tissues and single chain forms activated by proteases in the target; botulism and tetanus toxins; confine activity to target site; side effect reduction |
| 09/26/2002 | US20020137885 Corticotropin release inhibiting factor and methods of using same |
| 09/26/2002 | US20020137884 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 09/26/2002 | US20020137780 Differentiating agents for the treatment of inflammatory intestinal diseases |
| 09/26/2002 | US20020137720 Polynucleotide sequence; drug |
| 09/26/2002 | US20020137705 Osteoporosis |
| 09/26/2002 | US20020137703 Genetic engineering; insertion vector into polypeptides |
| 09/26/2002 | US20020137702 Yeast receptor |
| 09/26/2002 | US20020137700 Nucleic acids; genetic engineering |
| 09/26/2002 | US20020137697 Chimeric receptor genes and cells transformed therewith |
| 09/26/2002 | US20020137683 For malignant melanoma and carcinoma of colon/rectum, ovaries, lungs, and prostates; epitopic; immunogens which elicit cytotoxic T lymphocyte responses |
| 09/26/2002 | US20020137682 Coupling spin probes such as 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid for immunoassay |
| 09/26/2002 | US20020137681 Treatment of demyelinating autoimmune disease with ordered peptides |
| 09/26/2002 | US20020137679 Thrombospondins-1 and -2 are adhesive glycoproteins proteins that are angiogenesis inhibitors; portions of TSP- 1, TSP-2, endostatin, angiostatin, platelet factor 4, or prolactin linked to a portion of cartilage oligoeric matrix protein |
| 09/26/2002 | US20020137677 Soluble zalpha11 cytokine receptors |
| 09/26/2002 | US20020137675 Polypeptides, termed PROTX polypeptides, as well as polynucleotides encoding PROTX and antibodies that immuno-specifically bind to a PROTX, variant, mutant, or fragment of a PROTX; detection/treatment of pathological states; kits |
| 09/26/2002 | US20020137672 Radiolabeled annexins |
| 09/26/2002 | US20020137671 Production and use of modified cystatins |
| 09/26/2002 | US20020137666 Use of exendins and agonists thereof for the reduction of food intake |
| 09/26/2002 | US20020137661 Incubating parental polynucleotide variants under conditions to generate annealed polynucleotides of heteroduplexes, which are then exposed to a cellular DNA repair system to convert to parental variants or recombined variants |
| 09/26/2002 | US20020137213 Adenovirus particles with mutagenized fiber proteins |
| 09/26/2002 | US20020137212 Recombinant adenovirus expression vector as antitumor agents |
| 09/26/2002 | US20020137211 Method for establishing an expression system of spider dragline silk gene in bombyx mori |
| 09/26/2002 | US20020137205 Lipid uptake assays |
| 09/26/2002 | US20020137203 Identifying, testing, and treatments for diabetes and diabetic conditions and weight gain |
| 09/26/2002 | US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it |
| 09/26/2002 | US20020137191 May be used for the insertion of exogenous DNA sequences into the bacteria of the invention |
| 09/26/2002 | US20020137189 Cardiac hypertrophy factor and uses therefor |
| 09/26/2002 | US20020137188 Method of modulating cell survival and reagents useful for same |
| 09/26/2002 | US20020137186 Lymphotropic agents and vectors |
| 09/26/2002 | US20020137182 For obtaining and using a polypeptide other than oncogene BCL-2 that affects programmed vertebrate cell death |
| 09/26/2002 | US20020137180 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/26/2002 | US20020137168 Designated developmental tyrosine kinases; expressed in multipotential haematopoietic cells, in embryonic stem cells, in brain tissue and in testis, but are not expressed mature lineage-restricted haematopoetic cells |
| 09/26/2002 | US20020137166 ASIP-related proteins |
| 09/26/2002 | US20020137161 Protein expression and structure solution using specific fusion vectors |
| 09/26/2002 | US20020137159 May be used to alleviate anxiety, promote beneficial moods, and to alter hypothalamic functions, such as satiety, energy balance, and reproductive biology |
| 09/26/2002 | US20020137156 Controlled dissolution crosslinked protein crystals |
| 09/26/2002 | US20020137146 Escherichia culture product |
| 09/26/2002 | US20020137145 Human erythropoietin gene: high level expression in stably transfected mammalian cells |
| 09/26/2002 | US20020137144 Culture product |
| 09/26/2002 | US20020137143 Antigrowth regulator; cell differentiation; anticarcinogenic agents |
| 09/26/2002 | US20020137142 Tango-73 nucleic acids |
| 09/26/2002 | US20020137138 Modulating serotonin activity |
| 09/26/2002 | US20020137137 Genetic engineering; polypeptides |